5 Stocks Pulling The Health Care Sector Downward

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 175 points (-1.2%) at 14,582 as of Wednesday, April 17, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 512 issues advancing vs. 2,465 declining with 93 unchanged.

The Health Care sector currently sits down 1.45 versus the S&P 500, which is down 1.75. On the negative front, top decliners within the sector include Sanofi ( SNY), down 3.81, Regeneron Pharmaceuticals ( REGN), down 3.15, Novartis ( NVS), down 2.67, Amgen ( AMGN), down 2.05 and Novo Nordisk A/S ( NVO), down 1.73.

TheStreet Ratings group would like to highlight 5 stocks pushing the sector lower today:

5. Aetna ( AET) is one of the companies pushing the Health Care sector lower today. As of noon trading, Aetna is down $1.48 (-2.6%) to $55.16 on average volume Thus far, 1.3 million shares of Aetna exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $54.98-$56.35 after having opened the day at $56.33 as compared to the previous trading day's close of $56.64.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $18.0 billion and is part of the health services industry. The company has a P/E ratio of 11.5, below the S&P 500 P/E ratio of 17.7. Shares are up 22.3% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Aetna Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

4. As of noon trading, Medtronic ( MDT) is down $0.49 (-1.1%) to $46.16 on average volume Thus far, 2.2 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $46.06-$46.71 after having opened the day at $46.51 as compared to the previous trading day's close of $46.65.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $46.9 billion and is part of the health services industry. The company has a P/E ratio of 14.1, below the S&P 500 P/E ratio of 17.7. Shares are up 13.7% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Medtronic Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

3. As of noon trading, Express Scripts ( ESRX) is down $0.89 (-1.6%) to $55.30 on light volume Thus far, 2.0 million shares of Express Scripts exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $55.02-$55.95 after having opened the day at $55.84 as compared to the previous trading day's close of $56.19.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $45.3 billion and is part of the health services industry. The company has a P/E ratio of 30.9, above the S&P 500 P/E ratio of 17.7. Shares are up 2.3% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, increase in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Express Scripts Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

2. As of noon trading, UnitedHealth Group ( UNH) is down $0.61 (-1.0%) to $62.20 on average volume Thus far, 4.2 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 6.3 million shares. The stock has ranged in price between $62.20-$63.15 after having opened the day at $62.39 as compared to the previous trading day's close of $62.81.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $63.1 billion and is part of the health services industry. The company has a P/E ratio of 11.7, below the S&P 500 P/E ratio of 17.7. Shares are up 15.8% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full UnitedHealth Group Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

1. As of noon trading, Pfizer ( PFE) is down $0.22 (-0.7%) to $30.72 on average volume Thus far, 17.0 million shares of Pfizer exchanged hands as compared to its average daily volume of 32.3 million shares. The stock has ranged in price between $30.52-$30.90 after having opened the day at $30.80 as compared to the previous trading day's close of $30.94.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Pfizer has a market cap of $218.8 billion and is part of the drugs industry. The company has a P/E ratio of 24.2, above the S&P 500 P/E ratio of 17.7. Shares are up 23.4% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Pfizer Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
null

If you liked this article you might like

24 Stocks Hedge Funds Are Loving Right Now

24 Stocks Hedge Funds Are Loving Right Now

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely